Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. Articles
  3. neurology drug
Show results for
Products

Companies

News
Articles

Refine by
Date

  • Older

Neurology Drug Articles & Analysis

8 articles found

How Is Frontotemporal Dementia Different From Alzheimer`s?

How Is Frontotemporal Dementia Different From Alzheimer`s?

People living with frontotemporal dementia, or FTD, are commonly misdiagnosed with psychiatric disorders or Alzheimer’s disease and other causes of dementia, such as Parkinson’s disease and vascular dementia. While frontotemporal dementia and Alzheimer’s disease can both cause dementia, there are distinct differences in impacted regions of the brain and, consequently, ...

ByAltoida, Inc.


Learning How Meditation Helps the Brain

Learning How Meditation Helps the Brain

Meditation is often thought of as an avenue to clarity and self-awareness, but it may also be an avenue to better brain health. Emerging research suggests meditation may have significant benefits to brain health, ranging from improved mental and behavioral health to enhanced cognitive function. In this article, we will break down how meditation helps the brain and provide helpful tips for ...

ByAltoida, Inc.


Understanding the Stages: Preclinical Alzheimer`s Disease

Understanding the Stages: Preclinical Alzheimer`s Disease

Many neurological diseases, including Alzheimer’s disease, can be thought of as continuums, whether the presence and manifestation of the disease are different depending on the stage of the disease. In this article, we provide a high-level overview of the stages in the Alzheimer's disease continuum, with a focus on preclinical Alzheimer’s disease and its importance in patient care and ...

ByAltoida, Inc.


Digital Endpoints in Clinical Trials for Neurology: Benefits and Impediments to Adoption

Digital Endpoints in Clinical Trials for Neurology: Benefits and Impediments to Adoption

In addition to the pandemic, the digitization of healthcare is rapidly shifting clinical trials from analog to hybrid or fully decentralized clinical trials, catalyzing the development and implementation of digital health technologies to support clinical research. Digital endpoints not only support the decentralization of clinical trials but also provide a means to collect more sensitive, ...

ByAltoida, Inc.


Signs of Parkinson’s Disease to Watch For

Signs of Parkinson’s Disease to Watch For

Parkinson’s disease is a progressive neurodegenerative disease that is most commonly known for affecting movement. It primarily impacts dopaminergic, or dopamine-producing, neurons in a specific area of the brain known as the substantia nigra. Typically, symptoms develop slowly over years and continue to worsen as the disease progresses. While the manifestation of symptoms tends to vary ...

ByAltoida, Inc.


Research Shows a Link Between Loneliness and Dementia

Research Shows a Link Between Loneliness and Dementia

Humans are inherently social beings who thrive on making and maintaining social relationships. Connecting with and supporting one another forms deep bonds that make us feel seen, valued, and like we belong. These social interactions are not only important for our emotional well-being but also for our physical well-being-maybe even more so than originally thought. Loneliness, an increasingly ...

ByAltoida, Inc.


The Benefits of Decentralized Clinical Trials for Neurology

The Benefits of Decentralized Clinical Trials for Neurology

The COVID-19 pandemic has catalyzed the implementation of decentralized clinical trials in neurology, bringing the immense benefits of clinical trials to light. This industry-wide push towards trial decentralization has emerged as a key element for improving clinical trial efficiency and improving the experience for patients and physicians. By utilizing digital technologies, such as wearables, ...

ByAltoida, Inc.


Active pharmaceutical ingredients in wastewater: who are the major contributors?

Active pharmaceutical ingredients in wastewater: who are the major contributors?

However, more research is needed to understand the environmental effects of neurological drugs, whose emissions were in some cases relatively high. ...

ByEuropean Commission, Environment DG

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT